HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme 		Help

New: Introducing the Finviz Crypto Map

Learn More
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#101 / 200 Total
SOAR - Volato Group Inc - Stock Price Chart
TickerSOAR [AMEX]
CompanyVolato Group Inc
CountryUSA
IndustryAirports & Air Services
Market Cap3.66MEPS (ttm)-19.11
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.04EPS next 5Y-
P/B-EPS Q/Q100.59%
Dividend-Sales Q/Q92.89%
Insider Own53.89%Inst Own1.42%
Insider Trans-2.28%Inst Trans-10.90%
Short Float9.97%Earnings-
Analyst Recom-Target Price-
Avg Volume1.69M52W Range1.14 - 21.49
Jun-30-25 08:00AM Volato Sells GC Aviation for $2 Million, Strengthening Focus on Scalable Platform Growth (GlobeNewswire)
Jun-26-25 08:00AM Vaunt Adds Leviate Air to Operator Network, Expanding Access to Iconic HondaJet Experience (GlobeNewswire) -6.85%
Jun-17-25 08:00AM Vaunt Projects 85% Sequential Growth in Subscription Sale as Demand Surges (GlobeNewswire)
Jun-12-25 08:00AM Volato to Combine with M2i Global in a Strategic Transaction, Unlocking Value Through Industrial Scale and Platform Independence (Business Wire)
Jun-05-25 08:00AM Volato Projects Full-Year Profitability on Strength of Q1 Execution and Expanding Revenue Streams (Business Wire)
Jun-04-25 08:00AM Volato to Participate in Jefferies Virtual Business Aviation Summit (Business Wire) -21.67%
Jun-03-25 08:00AM Volato Aircraft-Trading Program Delivers Strong Q1 Results; New Leasing Initiative Expands Revenue Opportunities (Business Wire)
May-29-25 08:00AM Vaunt Deepens Member Loyalty with Exclusive Event in Dallas Amid Rapid Platform Growth (Business Wire) -8.88%
May-15-25 04:05PM Volato Reports Positive Net Income in Q1 2025 and Over $20 Million in Debt Reduction; Targets Additional Settlements and Capital Raise to Extend Operating Runway (Business Wire)
Mar-27-25 08:30AM Vaunt Moves Beyond Private Jet Booking with End-to-End Travel Capability (Business Wire) -7.54%
TVGN - Tevogen Bio Holdings Inc - Stock Price Chart
TickerTVGN [NASD, RUT]
CompanyTevogen Bio Holdings Inc
CountryUSA
IndustryBiotechnology
Market Cap228.40MEPS (ttm)-0.19
P/E-EPS this Y43.59%
Forward P/E-EPS next Y-4.55%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q74.98%
Dividend-Sales Q/Q-
Insider Own78.07%Inst Own2.08%
Insider Trans-1.43%Inst Trans58.73%
Short Float4.96%EarningsMay 28
Analyst Recom1.00Target Price10.00
Avg Volume947.01K52W Range0.26 - 3.09
Today 12:36PM Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides (GlobeNewswire)
Jul-17-25 09:15AM Tevogen Signs Letter of Intent for New In-House Cell Therapy Manufacturing Facility (GlobeNewswire)
Jul-16-25 06:35PM From Clinics to Cancer Labs, AI Is Unlocking a New $100B+ Era in Medicine (PR Newswire)
11:57AM Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell Alpha Launch (GlobeNewswire)
Jul-14-25 09:30AM Tevogen.AI Builds Alpha Version of PredicTcell Model with Microsoft and Databricks; Observes Drastic Time Reduction in Target Analysis Translating to Potential Savings of Billions in Drug Development Costs (GlobeNewswire) +5.88%
Jul-10-25 03:13PM Tevogen's New Headquarters, Fully Funded by CEO, Centralizes R&D and AI Teams to Accelerate Innovation (GlobeNewswire)
Jun-30-25 02:28PM Tevogen CEO Contributes to Build-Out and First-Year Operations of New Headquarters (GlobeNewswire)
09:50AM AI Is Quietly Reinventing Healthcare--And Real Deployments Are Now Underway (PR Newswire)
Jun-18-25 08:30AM Tevogen Updates on Development of EBV-Specific T Cell Therapy with Support from AI-Powered Target Discovery (GlobeNewswire)
Jun-10-25 09:15AM Tevogen expands headquarters in Warren, New Jersey (TipRanks) +12.73%
OPTX - Syntec Optics Holdings Inc - Stock Price Chart
TickerOPTX [NASD]
CompanySyntec Optics Holdings Inc
CountryUSA
IndustryElectronic Components
Market Cap58.34MEPS (ttm)0.04
P/E38.41EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.15EPS next 5Y-
P/B4.81EPS Q/Q92.98%
Dividend-Sales Q/Q-
Insider Own83.69%Inst Own0.69%
Insider Trans0.00%Inst Trans6.11%
Short Float0.44%Earnings-
Analyst Recom-Target Price-
Avg Volume74.01K52W Range0.85 - 5.10
Today 08:00AM Syntec Optics (Nasdaq: OPTX) Expands into Products Enabling Rocket Propulsion in Defense and Space Market (GlobeNewswire) +20.45%
Jun-17-25 04:05PM Pitney Bowes Strengthens Board of Directors with the Appointment of Brent Rosenthal (Business Wire)
May-20-25 08:31AM Syntec Optics (Nasdaq: OPTX) Enabling Optics for Fusion Energy, Enters New End-Market (GlobeNewswire)
May-16-25 07:08AM The Zacks Analyst Blog Highlights Advanced Micro Devices, Union Pacific, Lowe's Companies and Syntec Optics (Zacks)
May-15-25 04:54PM Top Research Reports for AMD, Union Pacific & Lowe's (Zacks)
May-07-25 08:37AM Syntec Optics (Nasdaq: OPTX) Enabling Optics for Near Vision Correction (GlobeNewswire) -5.00%
Apr-29-25 08:29AM Syntec Optics (Nasdaq: OPTX) Adds Tom Lopa to the Team as Director of Opto-Mechanicals (GlobeNewswire)
Apr-22-25 08:15AM Syntec Optics (Nasdaq: OPTX) Announces $5.2 Million in New Orders for Defense Night Vision Goggle Optics (GlobeNewswire) +15.32%
Apr-15-25 08:45AM Syntec Optics (Nasdaq: OPTX) Receives Increased Demand Approaching $4M in 2025 for Defense Tech Optomechanicals (GlobeNewswire) +28.18%
Apr-10-25 08:45AM Syntec Optics (Nasdaq: OPTX) Secures New $2.1M Advanced Optics Order for Next Generation U.S. Defense Integrated Scopes (GlobeNewswire) -7.05%
ABCL - AbCellera Biologics Inc - Stock Price Chart
TickerABCL [NASD]
CompanyAbCellera Biologics Inc
CountryCanada
IndustryBiotechnology
Market Cap1.34BEPS (ttm)-0.57
P/E-EPS this Y-11.29%
Forward P/E-EPS next Y18.84%
PEG-EPS past 5Y-107.74%
P/S57.84EPS next 5Y0.83%
P/B1.31EPS Q/Q-10.45%
Dividend-Sales Q/Q-57.45%
Insider Own24.97%Inst Own41.09%
Insider Trans0.00%Inst Trans12.97%
Short Float13.58%EarningsAug 07/a
Analyst Recom1.25Target Price9.17
Avg Volume5.64M52W Range1.89 - 4.46
Jul-07-25 04:05PM AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025 (Business Wire) +6.05%
09:11AM Truist Financial Lowers PT on AbCellera Biologics (ABCL) to $10 From $28, Keeps a Buy Rating (Insider Monkey)
Jun-25-25 04:09AM AbCellera Biologics Secures Patent Validity Affirmation for Microfluidic Cell Culture Technology (Insider Monkey)
Jun-09-25 09:13AM AbCellera Biologics Inc. (ABCL): A Bull Case Theory (Insider Monkey)
Jun-03-25 12:00PM ABCELLERA BIOLG (ABCL) Upgraded to Buy: Here's Why (Zacks) +7.94%
Jun-02-25 06:45PM Why AbCellera Biologics Stock Raced Nearly 6% Higher Today (Motley Fool) +5.94%
May-30-25 01:00PM AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575 (Business Wire)
May-21-25 11:21AM AbCellera Biologics Inc. (ABCL): Analysts See 474% Upside Potential (Insider Monkey)
May-14-25 05:00PM AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause (Business Wire)
May-12-25 03:30PM AbCelleras Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit (Business Wire)
ATAI - ATAI Life Sciences N.V - Stock Price Chart
TickerATAI [NASD]
CompanyATAI Life Sciences N.V
CountryNetherlands
IndustryBiotechnology
Market Cap648.43MEPS (ttm)-0.80
P/E-EPS this Y50.00%
Forward P/E-EPS next Y-7.70%
PEG-EPS past 5Y18.62%
P/S1964.94EPS next 5Y29.93%
P/B4.24EPS Q/Q-30.12%
Dividend-Sales Q/Q8538.89%
Insider Own31.72%Inst Own10.04%
Insider Trans24.31%Inst Trans20.58%
Short Float7.43%EarningsMay 14/b
Analyst Recom1.00Target Price10.20
Avg Volume3.51M52W Range1.03 - 2.98
Jul-11-25 07:13PM Aegis Capital Reaffirms Buy on Atai Life Sciences N.V. (ATAI) with $8 Target (Insider Monkey)
09:40AM Is atai Life Sciences (ATAI) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jul-09-25 10:36AM Canaccord Genuity Lifts Atai Life Sciences N.V. (ATAI)'s Price Target To $12, Maintains Buy Rating (Insider Monkey)
07:19AM Atai Life Sciences, Beckley Psytech Announce Positive Topline Results for BPL-003 (Insider Monkey)
Jul-06-25 05:30AM The MAHA Movement Loves Psychedelics. Should Wall Street? (The Wall Street Journal)
Jul-01-25 03:06PM A Promising Depression Drug Works. Psychedelics Are Back. (Barrons.com) +23.74%
12:04PM atai and Beckley Psytechs psychedelic wins in Phase IIb depression trial (Clinical Trials Arena)
07:15AM Atai and Beckley, set to merge, reveal study success for psychedelic drug (BioPharma Dive)
06:05AM atai Life Sciences Announces $50 Million Private Placement Financing (GlobeNewswire)
06:00AM atai Life Sciences and Beckley Psytech Announce Positive Topline Results from the Phase 2b Study of BPL-003 in Patients with Treatment-Resistant Depression (GlobeNewswire)
GRO - Brazil Potash Corp - Stock Price Chart
TickerGRO [AMEX]
CompanyBrazil Potash Corp
CountryCanada
IndustryOther Industrial Metals & Mining
Market Cap56.08MEPS (ttm)-
P/E-EPS this Y75.78%
Forward P/E-EPS next Y-6.45%
PEG-EPS past 5Y-18.07%
P/S-EPS next 5Y-
P/B0.28EPS Q/Q-1206.84%
Dividend-Sales Q/Q-
Insider Own45.86%Inst Own2.29%
Insider Trans0.00%Inst Trans-0.18%
Short Float0.33%EarningsMay 10/a
Analyst Recom1.00Target Price5.50
Avg Volume1.01M52W Range1.25 - 15.00
Jul-15-25 06:45AM Brazil Potash to Host Conference Call to Discuss Signing of ~$220M Memorandum of Understanding With Fictor Energia (GlobeNewswire) +32.41%
Jul-14-25 04:01PM Brazil Potash Signs Memorandum of Understanding for ~$200m Power Line Construction and $20m Investment With Fictor Energia (GlobeNewswire)
Jun-05-25 06:45AM Brazil Potash Announces Organizational Change at Potássio do Brasil (GlobeNewswire) -5.59%
06:45AM Brazil Potash Announces Organizational Change at Potassio do Brasil (GlobeNewswire)
Jun-02-25 06:45AM Brazil Potash Year to Date Summary: Company Achieves Milestones, Advancing Strategic Autazes Project Further Towards Construction (GlobeNewswire)
May-27-25 06:45AM Brazil Potash Announces Launch of Brazilian Depositary Receipts (BDRs) on B3 Exchange (GlobeNewswire) +42.22%
May-22-25 06:45AM Brazil Potash Announces Completion of Site Preparation Work at Future Port Terminal for Autazes Project (GlobeNewswire)
May-06-25 06:45AM Brazil Potash Announces Agreement for up to $75 Million Equity Line of Credit From Alumni Capital (GlobeNewswire)
May-01-25 08:00PM Brazil Potash Announces Participation in Upcoming Investor Conferences and Going Concern Qualification (GlobeNewswire)
Apr-24-25 04:05PM Brazil Potash Expands Advisory Board With Appointment of Marcelo Lessa, Former Executive of IFC/World Bank and Bunge Ltda. (GlobeNewswire) -9.22% -8.98%
INKT - MiNK Therapeutics Inc - Stock Price Chart
TickerINKT [NASD]
CompanyMiNK Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap80.95MEPS (ttm)-2.50
P/E-EPS this Y20.16%
Forward P/E-EPS next Y-3.94%
PEG-EPS past 5Y16.86%
P/S-EPS next 5Y5.20%
P/B-EPS Q/Q36.60%
Dividend-Sales Q/Q-
Insider Own75.14%Inst Own1.58%
Insider Trans0.00%Inst Trans-21.92%
Short Float1.30%EarningsMay 15/b
Analyst Recom2.33Target Price39.00
Avg Volume943.87K52W Range4.56 - 76.00
Jul-15-25 08:21AM MiNK Therapeutics Announces Frontiers in Immunology Publication Highlighting iNKT Cells as a Dual-Function Platform Key to Overcoming Barriers in Solid Tumor Cell Therapy (GlobeNewswire) -31.03%
Jul-14-25 08:04AM MiNK Therapeutics stock falls after William Blair downgrade (Investing.com) -36.71%
Jul-11-25 07:30AM MiNK Therapeutics Announces Publication of Complete Remission Following Allogeneic iNKT Cell Therapy in Metastatic Testicular Cancer (GlobeNewswire) +730.14%
Jun-10-25 01:33PM MiNK Therapeutics Announces Virtual Annual Shareholders Meeting (GlobeNewswire) +5.84%
Jun-02-25 09:29AM MiNK Therapeutics Awarded Prestigious NIAID Grant to Advance Allo-iNKT Cell Therapy for Prevention of GvHD in Stem Cell Transplant Patients (GlobeNewswire)
May-16-25 03:09AM MiNK Therapeutics Inc (INKT) Q1 2025 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com) +5.01%
May-15-25 11:48PM Q1 2025 Mink Therapeutics Inc Earnings Call (Thomson Reuters StreetEvents)
07:30AM MiNK Therapeutics Reports Q1 2025 Results and Highlights Clinical & Strategic Progress (GlobeNewswire)
May-05-25 12:30PM MiNK Therapeutics to Provide Corporate Update and First Quarter 2025 Financial Report (GlobeNewswire)
Mar-19-25 03:01AM MiNK Therapeutics Inc (INKT) Q4 2024 Earnings Call Highlights: Strategic Advances Amid ... (GuruFocus.com)
CRML - Critical Metals Corp - Stock Price Chart
TickerCRML [NASD, RUT]
CompanyCritical Metals Corp
CountryUnited Kingdom
IndustryOther Industrial Metals & Mining
Market Cap441.74MEPS (ttm)-1.96
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-1061.66%
P/S-EPS next 5Y-
P/B5.45EPS Q/Q-493.10%
Dividend-Sales Q/Q-
Insider Own78.38%Inst Own7.11%
Insider Trans0.00%Inst Trans11.39%
Short Float11.33%Earnings-
Analyst Recom-Target Price-
Avg Volume4.72M52W Range1.23 - 11.13
Jul-15-25 08:30AM Critical Metals Corp Targets Significantly Increased Resource Upgrade on 500MT Exploration Target within 4.7BT TREO (GlobeNewswire) +33.89%
08:01AM Critical Metals begins 2025 drilling program at Tanbreez project (Investing.com)
Jul-07-25 12:30AM USCM Completes Acquisition of Clayton Ridge Lithium Project (Newsfile) -7.47%
Jun-26-25 08:00AM USCM Identifies Black Shale Uranium and Potential CRD Mineralization at Long Canyon (Newsfile) +32.13%
Jun-23-25 08:30AM Critical Metals Corp Signs Infill Diamond Drilling Program to Significantly Increase the Size of the Resource at Tanbreez (GlobeNewswire)
Jun-16-25 08:00AM Critical Metals Corp Secures US$120,000,000 LOI for a 15-Year Term Loan From the US Federal Government Bank (EXIM Bank) for the Development of its Tanbreez Rare Earth Project in Greenland (GlobeNewswire) +49.26%
Jun-09-25 02:09PM Critical Metals Corp Releases Additional High-Grade REE Results From Diamond Drilling at Tanbreez in Greenland (GlobeNewswire) +5.84%
May-30-25 09:00AM Critical Metals announces gross proceeds of $2M from exercise of warrants (TipRanks)
May-29-25 08:56AM Critical Metals Corp Announces Gross Proceeds of $2MM USD from the Exercise of Warrants Priced at $5.00 USD from Institutional Fund (GlobeNewswire)
May-19-25 08:00AM Critical Metals Corp Releases Further Excellent Deep High-Grade Drilling Results on Tanbreez (TREO 0.48% & HREO 27%) (GlobeNewswire)
NVX - Novonix Limited ADR - Stock Price Chart
TickerNVX [NASD]
CompanyNovonix Limited ADR
CountryAustralia
IndustryElectrical Equipment & Parts
Market Cap248.12MEPS (ttm)-0.60
P/E-EPS this Y10.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-8.75%
P/S42.49EPS next 5Y-
P/B1.66EPS Q/Q-144.49%
Dividend-Sales Q/Q-25.56%
Insider Own-Inst Own0.42%
Insider Trans-Inst Trans187.52%
Short Float0.28%EarningsFeb 28/a
Analyst Recom1.00Target Price4.00
Avg Volume101.26K52W Range0.81 - 2.73
Today 12:38PM Battery-Material Stocks Soar After U.S. Unveils Chinese Graphite Tariffs (The Wall Street Journal) +5.41%
09:01AM U.S. Department of Commerce to Place 93.5% Antidumping Tariffs on Chinese Graphite Making the Effective Tariff Rate 160% (GlobeNewswire)
Jul-17-25 11:31PM Battery Material Stocks Jump after US Announces Graphite Duty (Bloomberg) +15.62%
May-21-25 07:12PM U.S. Department of Commerce to Place Up to 721% Tariffs on Chinese Graphite (GlobeNewswire) -15.33% +10.34%
May-02-25 11:03AM NOVONIX Limited (NVX) Q1 2025 Earnings Conference Call Transcript (Seeking Alpha)
Apr-29-25 06:34PM NOVONIX Finalizes Purchase and Sale Agreement for Enterprise South Land (GlobeNewswire) -5.04%
10:04AM Graphite Miners News For The Month Of April 2025 (Seeking Alpha)
Apr-27-25 07:38PM NOVONIX Appoints Michael O'Kronley as Chief Executive Officer (GlobeNewswire)
Mar-28-25 01:08PM Graphite Miners News For The Month Of March 2025 (Seeking Alpha) -10.85%
Mar-12-25 09:11PM NOVONIX Receives Approval for Purchase of Enterprise South Land for Planned Enterprise South Manufacturing Facility (GlobeNewswire)
BGLC - BioNexus Gene Lab Corp - Stock Price Chart
TickerBGLC [NASD]
CompanyBioNexus Gene Lab Corp
CountryMalaysia
IndustrySpecialty Chemicals
Market Cap9.16MEPS (ttm)-1.18
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-21.27%
P/S0.99EPS next 5Y-
P/B1.18EPS Q/Q-490.97%
Dividend-Sales Q/Q-10.28%
Insider Own34.65%Inst Own0.88%
Insider Trans0.00%Inst Trans-11.01%
Short Float0.70%Earnings-
Analyst Recom-Target Price-
Avg Volume1.10M52W Range2.01 - 15.60
Apr-30-25 11:25AM BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness (GlobeNewswire)
Apr-15-25 11:00AM BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory (GlobeNewswire) +14.22%
Mar-08-25 11:10AM Bionexus Gene Lab enters partnership with ML Tech (TipRanks)
Mar-07-25 11:00AM BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy (GlobeNewswire) +6.96%
Mar-05-25 11:00AM BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper (GlobeNewswire)
Sep-25-24 11:31AM BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd. (GlobeNewswire)
Sep-13-24 12:05PM BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd. (GlobeNewswire)
Sep-12-24 01:23PM BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions (GlobeNewswire) +8.36%
Sep-11-24 11:05AM BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production (GlobeNewswire)
Aug-27-24 11:35AM BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd (GlobeNewswire)
1⋯678910111213141516⋯20
Affiliate • Advertise • Theme Settings • Contact • Blog • Help • Privacy • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.